We are pleased to announce Mr. Jeffrey Stein as the newest member of CRIO’s Board of Directors!

Jeff Stein currently serves as the CEO and President of ALSA Research, which has been an early adopter of cloud-based technologies that are now standard practices across the clinical research industry. After beginning his career on Wall Street with Salomon Brothers, Jeff opened the firm’s London based MBS group. Shortly after, Jeff acquired a controlling interest in Healthcare Properties (HCP) where he served as managing partner. More recently, Jeff has taken on multiple leadership roles at several startup companies, including Matrix Medical Network and XTG LLC. Jeff’s expertise in healthcare technology will play a vital role in advancing our organization.

We’ve known Jeff for years, and couldn’t think of a better person to be on our Board of Directors. Jeff is forward-thinking, with a broad knowledge of the industry and a sophisticated understanding of business.

-Raymond Nomizu, CEO

Raymond and I have shared a vision for the development and use of eSource in clinical trials since before a single line of code was ever written. I became an investor in CRIO and a beta site user with the very first release. I am delighted to join this board and am excited about the future of the company.

-Jeff Stein

We are grateful for our entire Board of Directors for their commitment to our company, partners and clients. Please join us in welcoming Jeff to the CRIO family!

SDC Announces Partnership with CRIO on eSource Initiative

Boston, MA – Continuing the momentum of technology solution innovations after its recent release of SDC Insights™, SDC is proud to partner with CRIO to bring eSource functionality in-house to better serve clients and their clinical needs. “With SDC’s in-house developers, we can efficiently meet the individual needs of each protocol with CRIO eSource, a...

CRIO Joins Forces with the Association of Diversity in Clinical Trials as a Supporting Partner to Drive Inclusive Research Advancements

DALLAS, Aug. 14, 2023 – The Association of Diversity in Clinical Trials (AOD) and CRIO, a leading eSource technology provider, are excited to announce a new partnership. CRIO’s software platform empowers research sites to run more effectively, enabling research in underserved communities. CRIO’s work aligns with AOD’s mission to establish standards and best practices for the...

CRIO Announces Partnership with Pluto Health to Expand and Accelerate Clinical Trial Access

Innovative solution benefits patients with access to clinical trials as a treatment option, ongoing personalized health insights, and ultimately speeding new treatments to market BOSTON, MA, July 19, 2023 – CRIO, a Boston-based healthcare technology company, in partnership with Pluto Health, a Durham, NC-based smart care coordination service company, announces the development of a scalable...